KRAS and colorectal carcinoma: The KRAS-RAF-MEK-ERK-Cyclin D1 signaling pathway is a key promoter of the CRC malignant process through its effects on cell proliferation [20, 21]; thus, we next determined whether miR-543 inhibits CRC cell proliferation by targeting KRAS.